Copyright Reports & Markets. All rights reserved.

Global Therapeutic Enzymes Market Insights and Forecast to 2027

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Therapeutic Enzymes Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Therapeutic Enzymes Market Size Growth Rate by Type
    • 1.4.2 Injectable
    • 1.4.3 Oral
    • 1.2.4 Topical
  • 1.3 Market by Application
    • 1.3.1 Global Therapeutic Enzymes Market Size Growth Rate by Application
    • 1.3.2 Gaucher Disease
    • 1.3.3 MPS Disease
    • 1.3.4 Gastrointestinal Diseases
    • 1.3.5 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Therapeutic Enzymes Sales Estimates and Forecasts 2016-2027
  • 2.2 Global Therapeutic Enzymes Revenue Estimates and Forecasts 2016-2027
  • 2.3 Global Therapeutic Enzymes Revenue by Region: 2016 VS 2021 VS 2027
  • 2.4 Global Top Therapeutic Enzymes Regions by Sales
    • 2.4.1 Global Top Therapeutic Enzymes Regions by Sales (2016-2021)
    • 2.4.2 Global Top Therapeutic Enzymes Regions by Sales (2022-2027)
  • 2.5 Global Top Therapeutic Enzymes Regions by Revenue
    • 2.5.1 Global Top Therapeutic Enzymes Regions by Revenue (2016-2021)
    • 2.5.2 Global Top Therapeutic Enzymes Regions by Revenue (2022-2027)
  • 2.6 North America
  • 2.7 Europe
  • 2.8 Asia-Pacific
  • 2.9 Latin America
  • 2.10 Middle East & Africa

3 Competition by Manufacturers

  • 3.1 Global Therapeutic Enzymes Sales by Manufacturers
    • 3.1.1 Global Top Therapeutic Enzymes Manufacturers by Sales (2016-2021)
    • 3.1.2 Global Top Therapeutic Enzymes Manufacturers Market Share by Sales (2016-2021)
    • 3.1.3 Global Top 10 and Top 5 Companies by Therapeutic Enzymes Sales in 2020
  • 3.2 Global Therapeutic Enzymes Revenue by Manufacturers
    • 3.2.1 Global Top Therapeutic Enzymes Manufacturers by Revenue (2016-2021)
    • 3.2.2 Global Top Therapeutic Enzymes Manufacturers Market Share by Revenue (2016-2021)
    • 3.2.3 Global Top 10 and Top 5 Companies by Therapeutic Enzymes Revenue in 2020
  • 3.3 Global Therapeutic Enzymes Sales Price by Manufacturers
  • 3.4 Analysis of Competitive Landscape
    • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Therapeutic Enzymes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4.3 Global Therapeutic Enzymes Manufacturers Geographical Distribution
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Therapeutic Enzymes Sales by Type
    • 4.1.1 Global Therapeutic Enzymes Historical Sales by Type (2016-2021)
    • 4.1.2 Global Therapeutic Enzymes Forecasted Sales by Type (2022-2027)
    • 4.1.3 Global Therapeutic Enzymes Sales Market Share by Type (2016-2027)
  • 4.2 Global Therapeutic Enzymes Revenue by Type
    • 4.2.1 Global Therapeutic Enzymes Historical Revenue by Type (2016-2021)
    • 4.2.2 Global Therapeutic Enzymes Forecasted Revenue by Type (2022-2027)
    • 4.2.3 Global Therapeutic Enzymes Revenue Market Share by Type (2016-2027)
  • 4.3 Global Therapeutic Enzymes Price by Type
    • 4.3.1 Global Therapeutic Enzymes Price by Type (2016-2021)
    • 4.3.2 Global Therapeutic Enzymes Price Forecast by Type (2022-2027)

5 Market Size by Application

  • 5.1 Global Therapeutic Enzymes Sales by Application
    • 5.1.1 Global Therapeutic Enzymes Historical Sales by Application (2016-2021)
    • 5.1.2 Global Therapeutic Enzymes Forecasted Sales by Application (2022-2027)
    • 5.1.3 Global Therapeutic Enzymes Sales Market Share by Application (2016-2027)
  • 5.2 Global Therapeutic Enzymes Revenue by Application
    • 5.2.1 Global Therapeutic Enzymes Historical Revenue by Application (2016-2021)
    • 5.2.2 Global Therapeutic Enzymes Forecasted Revenue by Application (2022-2027)
    • 5.2.3 Global Therapeutic Enzymes Revenue Market Share by Application (2016-2027)
  • 5.3 Global Therapeutic Enzymes Price by Application
    • 5.3.1 Global Therapeutic Enzymes Price by Application (2016-2021)
    • 5.3.2 Global Therapeutic Enzymes Price Forecast by Application (2022-2027)

6 North America

  • 6.1 North America Therapeutic Enzymes Market Size by Type
    • 6.1.1 North America Therapeutic Enzymes Sales by Type (2016-2027)
    • 6.1.2 North America Therapeutic Enzymes Revenue by Type (2016-2027)
  • 6.2 North America Therapeutic Enzymes Market Size by Application
    • 6.2.1 North America Therapeutic Enzymes Sales by Application (2016-2027)
    • 6.2.2 North America Therapeutic Enzymes Revenue by Application (2016-2027)
  • 6.3 North America Therapeutic Enzymes Market Size by Country
    • 6.3.1 North America Therapeutic Enzymes Sales by Country (2016-2027)
    • 6.3.2 North America Therapeutic Enzymes Revenue by Country (2016-2027)
    • 6.3.3 U.S.
    • 6.3.4 Canada

7 Europe

  • 7.1 Europe Therapeutic Enzymes Market Size by Type
    • 7.1.1 Europe Therapeutic Enzymes Sales by Type (2017-2027)
    • 7.1.2 Europe Therapeutic Enzymes Revenue by Type (2017-2027)
  • 7.2 Europe Therapeutic Enzymes Market Size by Application
    • 7.2.1 Europe Therapeutic Enzymes Sales by Application (2017-2027)
    • 7.2.2 Europe Therapeutic Enzymes Revenue by Application (2017-2027)
  • 7.3 Europe Therapeutic Enzymes Market Size by Country
    • 7.3.1 Europe Therapeutic Enzymes Sales by Country (2017-2027)
    • 7.3.2 Europe Therapeutic Enzymes Revenue by Country (2017-2027)
    • 7.3.3 Germany
    • 7.3.4 France
    • 7.3.5 U.K.
    • 7.3.6 Italy
    • 7.3.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Therapeutic Enzymes Market Size by Type
    • 8.1.1 Asia Pacific Therapeutic Enzymes Sales by Type (2018-2027)
    • 8.1.2 Asia Pacific Therapeutic Enzymes Revenue by Type (2018-2027)
  • 8.2 Asia Pacific Therapeutic Enzymes Market Size by Application
    • 8.2.1 Asia Pacific Therapeutic Enzymes Sales by Application (2018-2027)
    • 8.2.2 Asia Pacific Therapeutic Enzymes Revenue by Application (2018-2027)
  • 8.3 Asia Pacific Therapeutic Enzymes Market Size by Region
    • 8.3.1 Asia Pacific Therapeutic Enzymes Sales by Region (2018-2027)
    • 8.3.2 Asia Pacific Therapeutic Enzymes Revenue by Region (2018-2027)
    • 8.3.3 China
    • 8.3.4 Japan
    • 8.3.5 South Korea
    • 8.3.6 India
    • 8.3.7 Australia
    • 8.3.8 Taiwan
    • 8.3.9 Indonesia
    • 8.3.10 Thailand
    • 8.3.11 Malaysia
    • 8.3.12 Philippines

9 Latin America

  • 9.1 Latin America Therapeutic Enzymes Market Size by Type
    • 9.1.1 Latin America Therapeutic Enzymes Sales by Type (2019-2027)
    • 9.1.2 Latin America Therapeutic Enzymes Revenue by Type (2019-2027)
  • 9.2 Latin America Therapeutic Enzymes Market Size by Application
    • 9.2.1 Latin America Therapeutic Enzymes Sales by Application (2019-2027)
    • 9.2.2 Latin America Therapeutic Enzymes Revenue by Application (2019-2027)
  • 9.3 Latin America Therapeutic Enzymes Market Size by Country
    • 9.3.1 Latin America Therapeutic Enzymes Sales by Country (2019-2027)
    • 9.3.2 Latin America Therapeutic Enzymes Revenue by Country (2019-2027)
    • 9.3.3 Mexico
    • 9.3.4 Brazil
    • 9.3.5 Argentina

6 Middle East and Africa

  • 6.1 Middle East and Africa Therapeutic Enzymes Market Size by Type
    • 6.1.1 Middle East and Africa Therapeutic Enzymes Sales by Type (2016-2027)
    • 6.1.2 Middle East and Africa Therapeutic Enzymes Revenue by Type (2016-2027)
  • 6.2 Middle East and Africa Therapeutic Enzymes Market Size by Application
    • 6.2.1 Middle East and Africa Therapeutic Enzymes Sales by Application (2016-2027)
    • 6.2.2 Middle East and Africa Therapeutic Enzymes Revenue by Application (2016-2027)
  • 6.3 Middle East and Africa Therapeutic Enzymes Market Size by Country
    • 6.3.1 Middle East and Africa Therapeutic Enzymes Sales by Country (2016-2027)
    • 6.3.2 Middle East and Africa Therapeutic Enzymes Revenue by Country (2016-2027)
    • 6.3.3 Turkey
    • 6.3.4 Saudi Arabia
    • 6.3.5 U.A.E

11 Company Profiles

  • 11.1 Sanofi
    • 11.1.1 Sanofi Corporation Information
    • 11.1.2 Sanofi Overview
    • 11.1.3 Sanofi Therapeutic Enzymes Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 Sanofi Therapeutic Enzymes Product Description
    • 11.1.5 Sanofi Related Developments
  • 11.2 BioMarin
    • 11.2.1 BioMarin Corporation Information
    • 11.2.2 BioMarin Overview
    • 11.2.3 BioMarin Therapeutic Enzymes Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.2.4 BioMarin Therapeutic Enzymes Product Description
    • 11.2.5 BioMarin Related Developments
  • 11.3 AbbVie
    • 11.3.1 AbbVie Corporation Information
    • 11.3.2 AbbVie Overview
    • 11.3.3 AbbVie Therapeutic Enzymes Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.3.4 AbbVie Therapeutic Enzymes Product Description
    • 11.3.5 AbbVie Related Developments
  • 11.4 Shire
    • 11.4.1 Shire Corporation Information
    • 11.4.2 Shire Overview
    • 11.4.3 Shire Therapeutic Enzymes Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.4.4 Shire Therapeutic Enzymes Product Description
    • 11.4.5 Shire Related Developments
  • 11.5 Alexion
    • 11.5.1 Alexion Corporation Information
    • 11.5.2 Alexion Overview
    • 11.5.3 Alexion Therapeutic Enzymes Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.5.4 Alexion Therapeutic Enzymes Product Description
    • 11.5.5 Alexion Related Developments
  • 11.6 Horizon Pharma
    • 11.6.1 Horizon Pharma Corporation Information
    • 11.6.2 Horizon Pharma Overview
    • 11.6.3 Horizon Pharma Therapeutic Enzymes Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.6.4 Horizon Pharma Therapeutic Enzymes Product Description
    • 11.6.5 Horizon Pharma Related Developments
  • 11.7 Allergan
    • 11.7.1 Allergan Corporation Information
    • 11.7.2 Allergan Overview
    • 11.7.3 Allergan Therapeutic Enzymes Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.7.4 Allergan Therapeutic Enzymes Product Description
    • 11.7.5 Allergan Related Developments
  • 11.8 Johnson & Johnson
    • 11.8.1 Johnson & Johnson Corporation Information
    • 11.8.2 Johnson & Johnson Overview
    • 11.8.3 Johnson & Johnson Therapeutic Enzymes Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.8.4 Johnson & Johnson Therapeutic Enzymes Product Description
    • 11.8.5 Johnson & Johnson Related Developments
  • 11.9 Recordati Rare Diseases
    • 11.9.1 Recordati Rare Diseases Corporation Information
    • 11.9.2 Recordati Rare Diseases Overview
    • 11.9.3 Recordati Rare Diseases Therapeutic Enzymes Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.9.4 Recordati Rare Diseases Therapeutic Enzymes Product Description
    • 11.9.5 Recordati Rare Diseases Related Developments
  • 11.10 Pfizer
    • 11.10.1 Pfizer Corporation Information
    • 11.10.2 Pfizer Overview
    • 11.10.3 Pfizer Therapeutic Enzymes Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.10.4 Pfizer Therapeutic Enzymes Product Description
    • 11.10.5 Pfizer Related Developments
  • 11.1 Sanofi
    • 11.1.1 Sanofi Corporation Information
    • 11.1.2 Sanofi Overview
    • 11.1.3 Sanofi Therapeutic Enzymes Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 Sanofi Therapeutic Enzymes Product Description
    • 11.1.5 Sanofi Related Developments
  • 11.12 Digestive Care
    • 11.12.1 Digestive Care Corporation Information
    • 11.12.2 Digestive Care Overview
    • 11.12.3 Digestive Care Therapeutic Enzymes Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.12.4 Digestive Care Product Description
    • 11.12.5 Digestive Care Related Developments
  • 11.13 Leadiant Biosciences
    • 11.13.1 Leadiant Biosciences Corporation Information
    • 11.13.2 Leadiant Biosciences Overview
    • 11.13.3 Leadiant Biosciences Therapeutic Enzymes Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.13.4 Leadiant Biosciences Product Description
    • 11.13.5 Leadiant Biosciences Related Developments

12 Value Chain and Sales Channels Analysis

  • 12.1 Therapeutic Enzymes Value Chain Analysis
  • 12.2 Therapeutic Enzymes Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Therapeutic Enzymes Production Mode & Process
  • 12.4 Therapeutic Enzymes Sales and Marketing
    • 12.4.1 Therapeutic Enzymes Sales Channels
    • 12.4.2 Therapeutic Enzymes Distributors
  • 12.5 Therapeutic Enzymes Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 13.1 Therapeutic Enzymes Industry Trends
  • 13.2 Therapeutic Enzymes Market Drivers
  • 13.3 Therapeutic Enzymes Market Challenges
  • 13.4 Therapeutic Enzymes Market Restraints

14 Key Findings in The Global Therapeutic Enzymes Study

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Author Details

    Therapeutic Enzymes market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Therapeutic Enzymes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

    Segment by Type
    Injectable
    Oral
    Topical
    Oral had the biggest market share of 94% in 2018.

    Segment by Application
    Gaucher Disease
    MPS Disease
    Gastrointestinal Diseases
    Others
    MPS Disease is the greatest segment of Therapeutic Enzymes application, with a share of 22% in 2018.

    By Company
    Sanofi
    BioMarin
    AbbVie
    Shire
    Alexion
    Horizon Pharma
    Allergan
    Johnson & Johnson
    Recordati Rare Diseases
    Pfizer
    Vivus
    Digestive Care
    Leadiant Biosciences

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia

    Buy now